ArticleFrontiers in pharmacology2022

RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.

Cong Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.